CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,339 enrolled
Drug / intervention
Ramelteondrug
Likely dose
Ramelteon 8 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02058992
NCT02058992N/ACompleted
CompareCT.gov

Rozerem Tablets 8mg Drug Use Surveillance: Survey on Insomnia Associated With Sleep-onset Difficulty

Takeda·observational·Posted Feb 11, 2014·Updated Jul 14, 2016

In Brief

An observational study evaluating Ramelteon for Insomnia. Completed, enrolled 3,339 participants.

Detailed Summary

The purpose of this study is to investigate the safety and efficacy of ramelteon (Rozerem) when used in the routine clinical setting in patients with sleep-onset difficulty associated with insomnia.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInsomnia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 11, 2014
Enrollment StartJul 1, 2010
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 12.4 years ago

Interventions

Ramelteondrug

Ramelteon 8 mg tablets